Viewing Study NCT02074657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-04-14 @ 1:49 AM
Study NCT ID: NCT02074657
Status: COMPLETED
Last Update Posted: 2016-12-20
First Post: 2014-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia
Sponsor: Hospital Universitario La Paz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module